Inheritance of a coding variant of the protein tyrosine phosphatase nonreceptor type 22 () gene is associated with increased susceptibility to autoimmunity and infection. Efforts to elucidate the mechanisms by which the variant modulates disease risk revealed that PTPN22 performs a signaling function in multiple biochemical pathways and cell types. Capable of both enzymatic activity and adaptor functions, PTPN22 modulates signaling through antigen and innate immune receptors. PTPN22 plays roles in lymphocyte development and activation, establishment of tolerance, and innate immune cell–mediated host defense and immunoregulation. The disease-associated PTPN22-R620W variant protein is likely involved in multiple stages of the pathogenesis of autoimmunity. Establishment of a tolerant B cell repertoire is disrupted by PTPN22-R620W action during immature B cell selection, and PTPN22-R620W alters mature T cell responsiveness. However, after autoimmune attack has initiated tissue injury, PTPN22-R620W may foster inflammation through modulating the balance of myeloid cell–produced cytokines.


Article metrics loading...

Loading full text...

Full text loading...


Literature Cited

  1. Matthews RJ, Bowne DB, Flores E, Thomas ML. 1.  1992. Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences. Mol. Cell. Biol. 12:2396–405 [Google Scholar]
  2. Cloutier JF, Veillette A. 2.  1996. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J. 15:4909–18 [Google Scholar]
  3. Cohen S, Dadi H, Shaoul E, Sharfe N, Roifman CM. 3.  1999. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 93:2013–24 [Google Scholar]
  4. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I. 4.  et al. 2004. Protein tyrosine phosphatases in the human genome. Cell 117:699–711 [Google Scholar]
  5. Tonks NK. 5.  2013. Protein tyrosine phosphatases—from housekeeping enzymes to master regulators of signal transduction. FEBS J. 280:346–78 [Google Scholar]
  6. Veillette A, Rhee I, Souza CM, Davidson D. 6.  2009. PEST family phosphatases in immunity, autoimmunity, and autoinflammatory disorders. Immunol. Rev. 228:312–24 [Google Scholar]
  7. Arimura Y, Yagi J. 7.  2010. Comprehensive expression profiles of genes for protein tyrosine phosphatases in immune cells. Sci. Signal. 3:rs1 [Google Scholar]
  8. Davidson D, Cloutier JF, Gregorieff A, Veillette A. 8.  1997. Inhibitory tyrosine protein kinase p50csk is associated with protein-tyrosine phosphatase PTP-PEST in hemopoietic and non-hemopoietic cells. J. Biol. Chem. 272:23455–62 [Google Scholar]
  9. Yu X, Sun JP, He Y, Guo X, Liu S. 9.  et al. 2007. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases. Proc. Natl. Acad. Sci. USA 104:19767–72 [Google Scholar]
  10. Tsai SJ, Sen U, Zhao L, Greenleaf WB, Dasgupta J. 10.  et al. 2009. Crystal structure of the human lymphoid tyrosine phosphatase catalytic domain: insights into redox regulation. Biochemistry 48:4838–45 [Google Scholar]
  11. Wu J, Katrekar A, Honigberg LA, Smith AM, Conn MT. 11.  et al. 2006. Identification of substrates of human protein-tyrosine phosphatase PTPN22. J. Biol. Chem. 281:11002–10 [Google Scholar]
  12. den Hertog J, Groen A, van der Wijk T. 12.  2005. Redox regulation of protein-tyrosine phosphatases. Arch. Biochem. Biophys. 434:11–15 [Google Scholar]
  13. Liu Y, Stanford SM, Jog SP, Fiorillo E, Orru V. 13.  et al. 2009. Regulation of lymphoid tyrosine phosphatase activity: inhibition of the catalytic domain by the proximal interdomain. Biochemistry 48:7525–32 [Google Scholar]
  14. Flores E, Roy G, Patel D, Shaw A, Thomas ML. 14.  1994. Nuclear localization of the PEP protein tyrosine phosphatase. Mol. Cell. Biol. 14:4938–46 [Google Scholar]
  15. Ronninger M, Guo Y, Shchetynsky K, Hill A, Khademi M. 15.  et al. 2012. The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controls. Genome Med. 4:2 [Google Scholar]
  16. Wang S, Dong H, Han J, Ho WT, Fu X, Zhao ZJ. 16.  2010. Identification of a variant form of tyrosine phosphatase LYP. BMC Mol. Biol. 11:78 [Google Scholar]
  17. Chang HH, Tai TS, Lu B, Iannaccone C, Cernadas M. 17.  et al. 2012. PTPN22.6, a dominant negative isoform of PTPN22 and potential biomarker of rheumatoid arthritis. PLoS ONE 7:e33067 [Google Scholar]
  18. Cloutier JF, Veillette A. 18.  1999. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J. Exp. Med. 189:111–21Ptpn22 forms a complex with Csk, and formation of the complex regulates phosphatase function in T cells. [Google Scholar]
  19. Hasegawa K, Martin F, Huang G, Tumas D, Diehl L, Chan AC. 19.  2004. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 303:685–89Ptpn22 deficiency results in augmented TCR signaling and thymocyte positive selection; no B cell–intrinsic phenotype. [Google Scholar]
  20. Brownlie RJ, Miosge LA, Vassilakos D, Svensson LM, Cope A, Zamoyska R. 20.  2012. Lack of the phosphatase PTPN22 increases adhesion of murine regulatory T cells to improve their immunosuppressive function. Sci. Signal. 5:ra87 [Google Scholar]
  21. Vang T, Liu WH, Delacroix L, Wu S, Vasile S. 21.  et al. 2012. LYP inhibits T-cell activation when dissociated from CSK. Nat. Chem. Biol. 8:437–46 [Google Scholar]
  22. Kane LP, Lin J, Weiss A. 22.  2000. Signal transduction by the TCR for antigen. Curr. Opin. Immunol. 12:242–49 [Google Scholar]
  23. Tybulewicz VL. 23.  2005. Vav-family proteins in T-cell signalling. Curr. Opin. Immunol. 17:267–74 [Google Scholar]
  24. Egerton M, Ashe OR, Chen D, Druker BJ, Burgess WH, Samelson LE. 24.  1992. VCP, the mammalian homolog of cdc48, is tyrosine phosphorylated in response to T cell antigen receptor activation. EMBO J. 11:3533–40 [Google Scholar]
  25. Meyer H, Bug M, Bremer S. 25.  2012. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat. Cell Biol. 14:117–23 [Google Scholar]
  26. Duan L, Reddi AL, Ghosh A, Dimri M, Band H. 26.  2004. The Cbl family and other ubiquitin ligases: destructive forces in control of antigen receptor signaling. Immunity 21:7–17 [Google Scholar]
  27. Fiorillo E, Orru V, Stanford SM, Liu Y, Salek M. 27.  et al. 2010. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. J. Biol. Chem. 285:26506–18 [Google Scholar]
  28. de la Puerta ML, Trinidad AG, Rodriguez Mdel C, de Pereda JM, Sanchez Crespo M. 28.  et al. 2013. The autoimmunity risk variant LYP-W620 cooperates with CSK in the regulation of TCR signaling. PLoS ONE 8:e54569 [Google Scholar]
  29. Chien W, Tidow N, Williamson EA, Shih LY, Krug U. 29.  et al. 2003. Characterization of a myeloid tyrosine phosphatase, Lyp, and its role in the Bcr-Abl signal transduction pathway. J. Biol. Chem. 278:27413–20 [Google Scholar]
  30. Konigsberger S, Peckl-Schmid D, Zaborsky N, Patzak I, Kiefer F, Achatz G. 30.  2010. HPK1 associates with SKAP-HOM to negatively regulate Rap1-mediated B-lymphocyte adhesion. PLoS ONE 5:e12468 [Google Scholar]
  31. Yu X, Chen M, Zhang S, Yu ZH, Sun JP. 31.  et al. 2011. Substrate specificity of lymphoid-specific tyrosine phosphatase (Lyp) and identification of Src kinase-associated protein of 55 kDa homolog (SKAP-HOM) as a Lyp substrate. J. Biol. Chem. 286:30526–34 [Google Scholar]
  32. Gjorloff-Wingren A, Saxena M, Han S, Wang X, Alonso A. 32.  et al. 2000. Subcellular localization of intracellular protein tyrosine phosphatases in T cells. Eur. J. Immunol. 30:2412–21 [Google Scholar]
  33. Maine CJ, Hamilton-Williams EE, Cheung J, Stanford SM, Bottini N. 33.  et al. 2012. PTPN22 alters the development of regulatory T cells in the thymus. J. Immunol. 188:5267–75 [Google Scholar]
  34. Stanford SM, Krishnamurthy D, Falk MD, Messina R, Debnath B. 34.  et al. 2011. Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells. J. Med. Chem. 54:1640–54 [Google Scholar]
  35. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP. 35.  et al. 2004. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75:330–37PTPN22-C1858T carriage is associated with increased risk of RA. [Google Scholar]
  36. Gjorloff-Wingren A, Saxena M, Williams S, Hammi D, Mustelin T. 36.  1999. Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur. J. Immunol. 29:3845–54 [Google Scholar]
  37. Vang T, Congia M, Macis MD, Musumeci L, Orru V. 37.  et al. 2005. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet. 37:1317–19PTPN22-C1858T-carrier T1D patients display hyporesponsive T cells, suggesting PTPN22-W620 gain of function. [Google Scholar]
  38. Marson A, Kretschmer K, Frampton GM, Jacobsen ES, Polansky JK. 38.  et al. 2007. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445:931–35 [Google Scholar]
  39. Zikherman J, Hermiston M, Steiner D, Hasegawa K, Chan A, Weiss A. 39.  2009. PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background. J. Immunol. 182:4093–106 [Google Scholar]
  40. Nika K, Soldani C, Salek M, Paster W, Gray A. 40.  et al. 2010. Constitutively active Lck kinase in T cells drives antigen receptor signal transduction. Immunity 32:766–77 [Google Scholar]
  41. Schmedt C, Saijo K, Niidome T, Kuhn R, Aizawa S, Tarakhovsky A. 41.  1998. Csk controls antigen receptor-mediated development and selection of T-lineage cells. Nature 394:901–4 [Google Scholar]
  42. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K. 42.  et al. 2004. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36:337–38PTPN22-C1858T carriage is associated with increased risk of T1D; variant protein shows defective Csk binding. [Google Scholar]
  43. Moran AE, Hogquist KA. 43.  2012. T-cell receptor affinity in thymic development. Immunology 135:261–67 [Google Scholar]
  44. Lu LF, Rudensky A. 44.  2009. Molecular orchestration of differentiation and function of regulatory T cells. Genes Dev. 23:1270–82 [Google Scholar]
  45. Zheng P, Kissler S. 45.  2013. PTPN22 silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant. Diabetes 62:896–904 [Google Scholar]
  46. Dai X, James RG, Habib T, Singh S, Jackson S. 46.  et al. 2013. A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J. Clin. Investig. 123:2024–36Ptpn22-R619W knock-in mice show autoantibodies and leukocyte infiltrates and enhanced TCR signaling, but no Ptpn22 stability defect. [Google Scholar]
  47. Zhang J, Zahir N, Jiang Q, Miliotis H, Heyraud S. 47.  et al. 2011. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat. Genet. 43:902–7Ptpn22-R619W knock-in mice display hyperresponsive T cells; variant protein shows reduced stability. [Google Scholar]
  48. Habib T, Funk A, Rieck M, Brahmandam A, Dai X. 48.  et al. 2012. Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant. J. Immunol. 188:487–96 [Google Scholar]
  49. Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. 49.  2007. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J. Immunol. 179:4704–10PTPN22-C1858T carriers display altered BCR signaling. [Google Scholar]
  50. Menard L, Saadoun D, Isnardi I, Ng YS, Meyers G. 50.  et al. 2011. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J. Clin. Investig. 121:3635–44Healthy PTPN22-C1858T carriers show defects at central and peripheral B cell tolerance checkpoints. [Google Scholar]
  51. Arechiga AF, Habib T, He Y, Zhang X, Zhang ZY. 51.  et al. 2009. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J. Immunol. 182:3343–47 [Google Scholar]
  52. Negro R, Gobessi S, Longo PG, He Y, Zhang ZY. 52.  et al. 2012. Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT. Blood 119:6278–87 [Google Scholar]
  53. Kawai T, Akira S. 53.  2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637–50 [Google Scholar]
  54. Heng TS, Painter MW. 54.  2008. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 9:1091–94 [Google Scholar]
  55. Liu J, Wang L, Harvey-White J, Osei-Hyiaman D, Razdan R. 55.  et al. 2006. A biosynthetic pathway for anandamide. Proc. Natl. Acad. Sci. USA 103:13345–50 [Google Scholar]
  56. Chevrier N, Mertins P, Artyomov MN, Shalek AK, Iannacone M. 56.  et al. 2011. Systematic discovery of TLR signaling components delineates viral-sensing circuits. Cell 147:853–67 [Google Scholar]
  57. Spalinger MR, Lang S, Weber A, Frei P, Fried M. 57.  et al. 2013. Loss of protein tyrosine phosphatase nonreceptor type 22 regulates interferon-γ-induced signaling in human monocytes. Gastroenterology 144:978–88 [Google Scholar]

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error